Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) — CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board. Dr. Wright has more than 30 years of experience in medicines development, having worked on both sides of the Atlantic in large and small pharmaceutical companies. He was Chief Medical Officer and a Main Board Director…

Source